Literature DB >> 26873381

Risk factors for long-term mortality of Staphylococcus aureus bacteremia.

D Yahav1,2, S Yassin3, H Shaked4, E Goldberg5,6, J Bishara4,5, M Paul5,7, L Leibovici5,8.   

Abstract

Staphylococcus aureus bacteremia (SAB) is a fatal disease. We aimed to describe risk factors for long-term mortality with SAB. We analyzed data from a retrospectively collected database including 1,692 patients with SAB. We considered variables of infection and background conditions for the analysis of long-term survival. The Kaplan-Meier procedure was used for analysis of long-term survival. Variables significantly associated with mortality were analyzed using a Cox regression model. We included 1,692 patients in the analysis. Patients were followed for up to 22 years. Within one year, 62% of patients died and within 5 years 72% died. A total of 82% of patients aged 65 years and older died within 5 years. Independent predictors of long-term mortality were older age (Hazard ratio 1.029, 95% confidence interval 1.022-1.036), female gender (HR 1.302, 95% CI 1.118-1.517), pneumonia or primary/ unknown source of infection (HR 1.441, 95% CI 1.230-1.689), dementia (HR 1.234, 95% CI 1.004-1.516), higher Charlson score (HR 1.155, 95% CI 1.115-1.196), shock at onset (HR 1.776, 95% CI 1.430-2.207) and arrival to hospitalization from an institution (HR 1.319, 95% CI 1.095-1.563). Long-term survival of patients older than 65 years and of women with SAB is severely curtailed.

Entities:  

Mesh:

Year:  2016        PMID: 26873381     DOI: 10.1007/s10096-016-2598-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005.

Authors:  T L Lamagni; N Potz; D Powell; R Pebody; J Wilson; G Duckworth
Journal:  J Hosp Infect       Date:  2010-10-28       Impact factor: 3.926

2.  Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia.

Authors:  F Hanses; C Spaeth; B P Ehrenstein; H-J Linde; J Schölmerich; B Salzberger
Journal:  Infection       Date:  2010-09-29       Impact factor: 3.553

Review 3.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

4.  A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.

Authors:  Lai Kin Yaw; James Owen Robinson; Kwok Ming Ho
Journal:  Lancet Infect Dis       Date:  2014-08-31       Impact factor: 25.071

5.  Does sex affect 30-day mortality in Staphylococcus aureus bacteremia?

Authors:  Nariman Mansur; Rawi Hazzan; Mical Paul; Jihad Bishara; Leonard Leibovici
Journal:  Gend Med       Date:  2012-11-07

Review 6.  Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Mical Paul; Galia Kariv; Elad Goldberg; Maria Raskin; Hila Shaked; Rawi Hazzan; Zmira Samra; Dina Paghis; Jihad Bishara; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2010-10-14       Impact factor: 5.790

7.  Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus.

Authors:  S Haessler; T Mackenzie; K B Kirkland
Journal:  J Hosp Infect       Date:  2008-03-19       Impact factor: 3.926

8.  Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005.

Authors:  C Allard; A Carignan; M Bergevin; I Boulais; V Tremblay; P Robichaud; R Duperval; J Pepin
Journal:  Clin Microbiol Infect       Date:  2008-03-04       Impact factor: 8.067

9.  Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.

Authors:  Yasmin Maor; Michal Hagin; Natasha Belausov; Nathan Keller; Debbi Ben-David; Galia Rahav
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

10.  Predicting risk for death from MRSA bacteremia.

Authors:  Mina Pastagia; Lawrence C Kleinman; Eliesel G Lacerda de la Cruz; Stephen G Jenkins
Journal:  Emerg Infect Dis       Date:  2012-07       Impact factor: 6.883

View more
  11 in total

1.  Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.

Authors:  E Forsblom; A Kakriainen; E Ruotsalainen; A Järvinen
Journal:  Infection       Date:  2018-09-07       Impact factor: 3.553

2.  A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations.

Authors:  John P Prybylski
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

3.  Cinnamaldehyde Inhibits Staphylococcus aureus Virulence Factors and Protects against Infection in a Galleria mellonella Model.

Authors:  Thiago A F Ferro; Jéssica M M Araújo; Bruna L Dos Santos Pinto; Jéssica S Dos Santos; Eliene B Souza; Bruna L R da Silva; Valderlane L P Colares; Tânia M G Novais; Clovis M B Filho; Carsten Struve; João B Calixto; Valério Monteiro-Neto; Luís C N da Silva; Elizabeth S Fernandes
Journal:  Front Microbiol       Date:  2016-12-21       Impact factor: 5.640

4.  Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.

Authors:  Natasha E Holmes; J Owen Robinson; Sebastiaan J van Hal; Wendy J Munckhof; Eugene Athan; Tony M Korman; Allen C Cheng; John D Turnidge; Paul D R Johnson; Benjamin P Howden
Journal:  BMC Infect Dis       Date:  2018-03-05       Impact factor: 3.090

5.  Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.

Authors:  Matthew P Cheng; Alexander Lawandi; Guillaume Butler-Laporte; Katryn Paquette; Todd C Lee
Journal:  Trials       Date:  2018-05-29       Impact factor: 2.279

6.  Risk factors for long-term mortality in patients admitted with severe infection.

Authors:  J Francisco; I Aragão; T Cardoso
Journal:  BMC Infect Dis       Date:  2018-04-05       Impact factor: 3.090

7.  Age-Dependent Increase in Incidence of Staphylococcus aureus Bacteremia, Denmark, 2008-2015.

Authors:  Louise Thorlacius-Ussing; Haakon Sandholdt; Anders Rhod Larsen; Andreas Petersen; Thomas Benfield
Journal:  Emerg Infect Dis       Date:  2019-05       Impact factor: 6.883

8.  Formal Infectious Diseases Specialist Consultation Improves Long-term Outcome of Methicillin-Sensitive Staphylococcus aureus Bacteremia.

Authors:  Erik Forsblom; Hanna Frilander; Eeva Ruotsalainen; Asko Järvinen
Journal:  Open Forum Infect Dis       Date:  2019-11-19       Impact factor: 3.835

9.  Evaluation of Factors which Influence Mortality in Gram-positive Bacteremia in Hemodialysis Patients.

Authors:  Kerry Anne Rambaran; Saeed K Alzghari; Charles F Seifert
Journal:  Cureus       Date:  2018-07-03

10.  Risk stratification biomarkers for Staphylococcus aureus bacteraemia.

Authors:  Yi Cao; Alessander O Guimaraes; Melicent C Peck; Oleg Mayba; Felicia Ruffin; Kyu Hong; Montserrat Carrasco-Triguero; Vance G Fowler; Stacey A Maskarinec; Carrie M Rosenberger
Journal:  Clin Transl Immunology       Date:  2020-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.